Pharmacy to Dose: The Critical Care Podcast cover image

Amiodarone v Lidocaine: Versus Series

Pharmacy to Dose: The Critical Care Podcast

00:00

The Limits of Randomized Trials

More people in this retrospective analysis were actually given light-acane than amiodorone. In the initial unadjusted analysis light-ACane was better across the board so nick light-acanes better ros 79 or 68 more survival to 24 hours better survival. When you match those patients they took 180 patients and matched them super well so really minimal differences all the covariate covariates controlled at baseline there was no differences among any of the outcomes.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app